Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Sahin, T.; Kemik, F.; Muglu, H.; Biter, S.; Tunbekici, S.; Oruc, A.; Guren, A.; Kaban, K.; Aykan, M.; Koylu, B.; Ekinci, O.; Onur, I. Deliktas; Kalem, A.; Altunok, O.; Seyyar, M.; Guney, B.; Akdogan, O.; Yazici, M.; Majidova, N.; Esin, E.; Cabuk, D.; Yazici, O.; Gursu, R.; Yilmaz, M.; Cinkir, H. Yesil; Ates, O.; Celik, E.; Karadurmus, N.; Mandel, N.; Bayoglu, I.; Araz, M.; Goker, E.; Bayram, E.; Erdem, D.; Selcukbiricik, F.; Basaran, G.; Sezer, A.; Bilici, A.; Gunduz, S.; Guven, D.; Aksoy, S.

doi:10.1158/1557-3265.SABCS25-PS5-05-14

Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Date

2026

Authors

dc.identifier.issn

1078-0432
1557-3265

dc.identifier.doi

10.1158/1557-3265.SABCS25-PS5-05-14

dc.description.volume

32

Publisher

AMER ASSOC CANCER RESEARCH

DOI

10.1158/1557-3265.SABCS25-PS5-05-14
10.1158/1557-3265.SABCS25-PS5-05-14

Keywords

Oncology

URI

https://doi.org/10.1158/1557-3265.SABCS25-PS5-05-14
https://openaccess.acibadem.edu.tr/handle/11443/11261

Collections

WOS

Full item page

Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By